The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Organ Preservation Solutions-Global Market Insights and Sales Trends 2024
Synopsis
The global Organ Preservation Solutions market size is expected to reach US$ 246.5 million by 2029, growing at a CAGR of 9.7% from 2023 to 2029. The market is mainly driven by the significant applications of Organ Preservation Solutions in various end use industries. The expanding demands from the Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS) and Others,, are propelling Organ Preservation Solutions market. Viaspan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Custodial segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Organ Preservation Solutions market, driven by demand from China, the second largest economy with some signs of stabilising, the Organ Preservation Solutions market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Organ Preservation Solutions, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Organ Preservation Solutions market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Organ Preservation Solutions market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Organ Preservation Solutions sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Organ Preservation Solutions covered in this report include Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB, ToleroTech, Inc, CryoLife, Inc. and Claris Lifesciences Limited, etc.
The global Organ Preservation Solutions market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Dr. Franz Köhler Chemie
Teva Pharmaceutical Industries Ltd.
Lifeline Scientific
Bristol-Myers Squibb
BioLife Solutions, Inc.
XVIVO Perfusion AB
ToleroTech, Inc
CryoLife, Inc.
Claris Lifesciences Limited
BioTime, Inc.
21st Century Medicine
Global Organ Preservation Solutions market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Organ Preservation Solutions market, Segment by Type:
Viaspan
Custodial
siRNA Transplant Solutions
Others
Global Organ Preservation Solutions market, by Application
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Organ Preservation Solutions companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Organ Preservation Solutions market size is expected to reach US$ 246.5 million by 2029, growing at a CAGR of 9.7% from 2023 to 2029. The market is mainly driven by the significant applications of Organ Preservation Solutions in various end use industries. The expanding demands from the Hypothermic Perfusion Preservation (HPP), Static Cold Storage (SCS) and Others,, are propelling Organ Preservation Solutions market. Viaspan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Custodial segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Organ Preservation Solutions market, driven by demand from China, the second largest economy with some signs of stabilising, the Organ Preservation Solutions market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Organ Preservation Solutions, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Organ Preservation Solutions market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Organ Preservation Solutions market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Organ Preservation Solutions sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Organ Preservation Solutions covered in this report include Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB, ToleroTech, Inc, CryoLife, Inc. and Claris Lifesciences Limited, etc.
The global Organ Preservation Solutions market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Dr. Franz Köhler Chemie
Teva Pharmaceutical Industries Ltd.
Lifeline Scientific
Bristol-Myers Squibb
BioLife Solutions, Inc.
XVIVO Perfusion AB
ToleroTech, Inc
CryoLife, Inc.
Claris Lifesciences Limited
BioTime, Inc.
21st Century Medicine
Global Organ Preservation Solutions market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Organ Preservation Solutions market, Segment by Type:
Viaspan
Custodial
siRNA Transplant Solutions
Others
Global Organ Preservation Solutions market, by Application
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Organ Preservation Solutions companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Organ Preservation Solutions
1.1 Organ Preservation Solutions Market Overview
1.1.1 Organ Preservation Solutions Product Scope
1.1.2 Organ Preservation Solutions Market Status and Outlook
1.2 Global Organ Preservation Solutions Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Organ Preservation Solutions Market Size by Region (2018-2029)
1.4 Global Organ Preservation Solutions Historic Market Size by Region (2018-2023)
1.5 Global Organ Preservation Solutions Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Organ Preservation Solutions Market Size (2018-2029)
1.6.1 North America Organ Preservation Solutions Market Size (2018-2029)
1.6.2 Europe Organ Preservation Solutions Market Size (2018-2029)
1.6.3 Asia-Pacific Organ Preservation Solutions Market Size (2018-2029)
1.6.4 Latin America Organ Preservation Solutions Market Size (2018-2029)
1.6.5 Middle East & Africa Organ Preservation Solutions Market Size (2018-2029)
2 Organ Preservation Solutions Market by Type
2.1 Introduction
2.1.1 Viaspan
2.1.2 Custodial
2.1.3 siRNA Transplant Solutions
2.1.4 Others
2.2 Global Organ Preservation Solutions Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Organ Preservation Solutions Historic Market Size by Type (2018-2023)
2.2.2 Global Organ Preservation Solutions Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Organ Preservation Solutions Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Organ Preservation Solutions Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Organ Preservation Solutions Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Organ Preservation Solutions Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Organ Preservation Solutions Revenue Breakdown by Type (2018-2029)
3 Organ Preservation Solutions Market Overview by Application
3.1 Introduction
3.1.1 Hypothermic Perfusion Preservation (HPP)
3.1.2 Static Cold Storage (SCS)
3.1.3 Others
3.2 Global Organ Preservation Solutions Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Organ Preservation Solutions Historic Market Size by Application (2018-2023)
3.2.2 Global Organ Preservation Solutions Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Organ Preservation Solutions Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Organ Preservation Solutions Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Organ Preservation Solutions Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Organ Preservation Solutions Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Organ Preservation Solutions Revenue Breakdown by Application (2018-2029)
4 Organ Preservation Solutions Competition Analysis by Players
4.1 Global Organ Preservation Solutions Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Preservation Solutions as of 2022)
4.3 Date of Key Players Enter into Organ Preservation Solutions Market
4.4 Global Top Players Organ Preservation Solutions Headquarters and Area Served
4.5 Key Players Organ Preservation Solutions Product Solution and Service
4.6 Competitive Status
4.6.1 Organ Preservation Solutions Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Dr. Franz Köhler Chemie
5.1.1 Dr. Franz Köhler Chemie Profile
5.1.2 Dr. Franz Köhler Chemie Main Business
5.1.3 Dr. Franz Köhler Chemie Organ Preservation Solutions Products, Services and Solutions
5.1.4 Dr. Franz Köhler Chemie Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.1.5 Dr. Franz Köhler Chemie Recent Developments
5.2 Teva Pharmaceutical Industries Ltd.
5.2.1 Teva Pharmaceutical Industries Ltd. Profile
5.2.2 Teva Pharmaceutical Industries Ltd. Main Business
5.2.3 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Products, Services and Solutions
5.2.4 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5.3 Lifeline Scientific
5.3.1 Lifeline Scientific Profile
5.3.2 Lifeline Scientific Main Business
5.3.3 Lifeline Scientific Organ Preservation Solutions Products, Services and Solutions
5.3.4 Lifeline Scientific Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.3.5 Bristol-Myers Squibb Recent Developments
5.4 Bristol-Myers Squibb
5.4.1 Bristol-Myers Squibb Profile
5.4.2 Bristol-Myers Squibb Main Business
5.4.3 Bristol-Myers Squibb Organ Preservation Solutions Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.4.5 Bristol-Myers Squibb Recent Developments
5.5 BioLife Solutions, Inc.
5.5.1 BioLife Solutions, Inc. Profile
5.5.2 BioLife Solutions, Inc. Main Business
5.5.3 BioLife Solutions, Inc. Organ Preservation Solutions Products, Services and Solutions
5.5.4 BioLife Solutions, Inc. Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.5.5 BioLife Solutions, Inc. Recent Developments
5.6 XVIVO Perfusion AB
5.6.1 XVIVO Perfusion AB Profile
5.6.2 XVIVO Perfusion AB Main Business
5.6.3 XVIVO Perfusion AB Organ Preservation Solutions Products, Services and Solutions
5.6.4 XVIVO Perfusion AB Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.6.5 XVIVO Perfusion AB Recent Developments
5.7 ToleroTech, Inc
5.7.1 ToleroTech, Inc Profile
5.7.2 ToleroTech, Inc Main Business
5.7.3 ToleroTech, Inc Organ Preservation Solutions Products, Services and Solutions
5.7.4 ToleroTech, Inc Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.7.5 ToleroTech, Inc Recent Developments
5.8 CryoLife, Inc.
5.8.1 CryoLife, Inc. Profile
5.8.2 CryoLife, Inc. Main Business
5.8.3 CryoLife, Inc. Organ Preservation Solutions Products, Services and Solutions
5.8.4 CryoLife, Inc. Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.8.5 CryoLife, Inc. Recent Developments
5.9 Claris Lifesciences Limited
5.9.1 Claris Lifesciences Limited Profile
5.9.2 Claris Lifesciences Limited Main Business
5.9.3 Claris Lifesciences Limited Organ Preservation Solutions Products, Services and Solutions
5.9.4 Claris Lifesciences Limited Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.9.5 Claris Lifesciences Limited Recent Developments
5.10 BioTime, Inc.
5.10.1 BioTime, Inc. Profile
5.10.2 BioTime, Inc. Main Business
5.10.3 BioTime, Inc. Organ Preservation Solutions Products, Services and Solutions
5.10.4 BioTime, Inc. Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.10.5 BioTime, Inc. Recent Developments
5.11 21st Century Medicine
5.11.1 21st Century Medicine Profile
5.11.2 21st Century Medicine Main Business
5.11.3 21st Century Medicine Organ Preservation Solutions Products, Services and Solutions
5.11.4 21st Century Medicine Organ Preservation Solutions Revenue (US$ Million) & (2018-2023)
5.11.5 21st Century Medicine Recent Developments
6 North America
6.1 North America Organ Preservation Solutions Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Organ Preservation Solutions Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Organ Preservation Solutions Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Organ Preservation Solutions Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Organ Preservation Solutions Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Organ Preservation Solutions Market Dynamics
11.1 Organ Preservation Solutions Industry Trends
11.2 Organ Preservation Solutions Market Drivers
11.3 Organ Preservation Solutions Market Challenges
11.4 Organ Preservation Solutions Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
